Sunshine Biopharma- Warrants (15/02/2027) Current Cash

Sunshine Biopharma- Warrants (15/02/2027) (SBFMW) currently reports a current cash of $14M as of June 2026. That compares with $10M in the prior-year period — up 33.4% year over year. Use the charts on this page to explore Sunshine Biopharma- Warrants (15/02/2027)'s current cash history and peer comparisons.

Sunshine Biopharma- Warrants (15/02/2027)'s current cash increased from $10M to $14M — a 33.4% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Sunshine Biopharma- Warrants (15/02/2027) reported $14M in current cash as of June 2026. That compares with $10M in the prior-year period — up 33.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $14M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Sunshine Biopharma- Warrants (15/02/2027), and consider following SBFMW for alerts when major investors trade the stock.

Sunshine Biopharma- Warrants (15/02/2027) is classified in the Healthcare sector. On current cash, it currently shows $14M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SBFMW with unrelated industries.